January 30, 2019
SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
Read More
January 30, 2019
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Read More
January 30, 2019
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Read More
January 30, 2019
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Read More
January 30, 2019
A Study to Assess the Immunogenicity and Safety of GSK Biologicals’ Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Read More
January 30, 2019
A Study to Assess the Immunogenicity and Safety of GSK Biologicals’ Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Read More
January 30, 2019
Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants
Read More
January 30, 2019
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
Read More
January 30, 2019
A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Read More
January 30, 2019
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer’s Disease Dementia
Read More
December 10, 2018
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Read More
Load More
X